Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001214659-17-006541
Filing Date
2017-11-08
Accepted
2017-11-08 17:04:27
Documents
55
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 a103117010q.htm 10-Q 937131
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 12814
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 12788
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 4146
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 4124
  Complete submission text file 0001214659-17-006541.txt   4068058

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT anth-20170930.xml EX-101.INS 681879
7 XBRL TAXONOMY EXTENSION SCHEMA anth-20170930.xsd EX-101.SCH 37950
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE anth-20170930_cal.xml EX-101.CAL 38966
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE anth-20170930_def.xml EX-101.DEF 209051
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE anth-20170930_lab.xml EX-101.LAB 311824
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anth-20170930_pre.xml EX-101.PRE 265505
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Filer) CIK: 0001316175 (see all company filings)

EIN.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34637 | Film No.: 171187404
SIC: 2834 Pharmaceutical Preparations